The three purest plays on the science are Illumina (NASDAQ: ILMN), Pacific Biosciences of California (NASDAQ: PACB) -- also known as PacBio -- and Oxford Nanopore Technologies (LSE: ONT). For shareholders of PacBio, it has never been about sales and profit.